Biologic and clinical evaluation of high intermittent dose all trans retinoic acid (ATRA) in refractory multiple myeloma (MM) patients (PTS).

被引：0
|
作者：
Hussein, MA [1 ]
Bocock, K [1 ]
Bloom, T [1 ]
Finke, J [1 ]
Rybicki, L [1 ]
Scott, R [1 ]
Bukowski, RM [1 ]
机构：
[1] Cleveland Clin, Ctr Canc, Cleveland, OH 44106 USA
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
444
引用
收藏
页码：108A / 109A
页数：2
相关论文
共 50 条
  • [11] Efficacy and Safety of Daratumumab Combined with All-Trans Retinoic Acid in Relapsed/Refractory Multiple Myeloma; Results of the Phase 1/2 Dara/ATRA Study
    Frerichs, Kristine A.
    Minnema, Monique C.
    Levin, Mark-David
    Broyl, Annemiek
    Bos, Gerard
    Kersten, Marie Jose
    Mutis, Tuna
    Verkleij, Christie P. M.
    Bosman, Patricia W. C.
    Klein, Saskia K.
    Zweegman, Sonja
    Sonneveld, Pieter
    Van de Donk, Niels W. C. J.
    BLOOD, 2019, 134
  • [12] ALL-TRANS-RETINOIC ACID FOR ADVANCED MULTIPLE-MYELOMA
    MUSTO, P
    FALCONE, A
    SAJEVA, MR
    DARENA, G
    BONINI, A
    CAROTENUTO, M
    BLOOD, 1995, 85 (12) : 3769 - 3770
  • [13] Monitoring patients that have received all-trans retinoic acid (ATRA) treatment diagnosed with retinoic acid syndrome.
    Privitere, Lisa
    Nokic, Merima
    ONCOLOGY NURSING FORUM, 2007, 34 (02) : 566 - 567
  • [14] All-trans retinoic acid (ATRA) in patients with chronic myeloid leukemia in the chronic phase
    Russo, D
    Regazzi, M
    Sacchi, S
    Visani, C
    Lazzarino, M
    Avvisati, G
    Pelicci, PG
    Dastoli, G
    Grandi, C
    Iacona, I
    Candoni, A
    Grattoni, R
    Galieni, P
    Rupoli, S
    Liberati, AM
    Maiolo, AT
    LEUKEMIA, 1998, 12 (04) : 449 - 454
  • [15] All-trans retinoic acid (ATRA) in patients with chronic myeloid leukemia in the chronic phase
    D Russo
    M Regazzi
    S Sacchi
    G Visani
    M Lazzarino
    G Avvisati
    PG Pelicci
    G Dastoli
    C Grandi
    I Iacona
    A Candoni
    R Grattoni
    P Galieni
    S Rupoli
    AM Liberati
    AT Maiolo
    Leukemia, 1998, 12 : 449 - 454
  • [16] Evaluation of immunomodulatory and antitumor activity of all trans retinoic acid (ATRA) in solid tumor bearing mice
    Siddikuzzaman
    Grace, Berlin V. M.
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2013, 35 (01) : 110 - 118
  • [17] Oral all-trans retinoic acid (ATRA): Administration in intubated patients with acute promyelocytic leukemia
    Bargetzi, MJ
    Tichelli, A
    Gratwohl, A
    Speck, B
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1996, 126 (45) : 1944 - 1945
  • [18] All-trans retinoic acid (ATRA) corrects the imbalance of macrophage polarization in patients with immune thrombocytopenia
    Feng, Q.
    Xu, M.
    Hou, Y.
    Yu, Y.
    Li, X.
    Sun, Y.
    Peng, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 195 - 195
  • [19] Dexamethasone, all-trans retinoic acid and interferon alpha 2a (Dai Regimen) in the treatment of refractory multiple myeloma (RMM).
    Aviles, A
    Rosas, A
    Cleto, S
    Diaz, N
    Garcia, EL
    BLOOD, 1997, 90 (10) : 4120 - 4120
  • [20] A phase II clinical study of arsenic trioxide (ATO) in patients(pts) with relapsed or refractory multiple myeloma (MM); a preliminary report
    Hussein, MA
    Mason, J
    Ravandi, F
    Rifkin, RM
    BLOOD, 2001, 98 (11) : 378A - 378A
12345